Recent headlines from the sources AlphaScala monitors. AlphaScala analysis is published in the main market section.
Intel’s $545B market cap prices in near-perfect foundry execution and CHIPS Act funding. Without marquee customers or margin proof, the 200% rally looks fragile.
Narrow market breadth and heavy options positioning leave the AI rally vulnerable to supply-chain shocks. Earnings season will test if AI demand translates into revenue.
Stock futures fell Friday after U.S.-China talks avoided chip restrictions. Traders also tracked Putin’s Beijing visit, Trump trades, and Walmart’s Flipkart.
The DAX fell 1.7% as inflation fears and stalled U.S.-China trade talks triggered profit-taking. Middle East tensions added a geopolitical risk bid.
Innovative Eyewear reported Q1 revenue of $773.6K, a 70% YoY increase, with cash at $5.68M and a GAAP loss of $0.37 per share. The cash runway now becomes the central question.
SpyGlass posted a $0.69 per-share loss; $251M cash funds operations through 2028. Phase 3 enrollment for its bimatoprost drug pad IOL is on track for 2027.
Chandan sees Nifty 27,000 fair value on accelerating profits and credit growth, but warns food inflation and monsoon are the next stress test for sentiment.
The record 38.6% margin signals the hub-and-powertrain shift is improving unit economics. 2026 revenue guidance holds at $40M–$50M. The next test comes with Q2 delivery data.
Dragonfly's Q2 sales guide of ~$13.2M, following a $3M+ trucking order, signals electrification demand. Readthrough for energy storage sector strengthens.
The slide deck for Faraday Future's Q1 2026 results is now public, giving investors a detailed look at the EV startup's cash position and production progress. The market will parse the deck for any changes to the FF 91 timeline.
Innventure posted $1.4M in Q1 revenue but disclosed $50M-plus in bookings, setting a $100M exit run-rate target for Accelsius by 2026. The gap defines the stock's next move.
AI Knowledge ARR climbed 26% in Q3. Higher U.S. RFP activity, new product launches, and a Q4 revenue view of $22.5M-$23.0M set the stage for the FY 2026 ramp.
The Q1 2026 presentation for Service Properties Trust (SVC) is now public. Investors will parse occupancy, RevPAR, and guidance for signs of a sustained hotel recovery.
RideNow's Q1 2026 call outlined an accretive acquisition strategy and a longer-term ~2x leverage goal. Refinancing progress and SEC update also in focus. Next: deal announcements.
Consensus calls for a $0.19 per-share loss on $15.49M in revenue. The report will test whether Surgepays can narrow losses and preserve cash as it scales its underbanked fintech platform.
Consensus calls for a loss of -$0.34 per share on $5.78M revenue. The May 14 after-close report tests whether Lifeward's beat streak and year-over-year growth can sustain the stock's recent range.
With cash at $1.2M and a quarterly burn of $5.2M, Stardust Power faces a financing decision that will determine dilution risk. The next capital raise filing is the critical catalyst.
Celcuity's $387M cash position funds operations through 2027. Rising operating cash use could shorten that runway. Alpha Score 35 signals weak momentum.
SGMT shares are up >30% in a month, giving the company a ~$450M market cap, but the stock remains >50% below its prior peak. The next denifanstat readout is the binary catalyst.
Higher rate expectations are widening the net interest margin outlook for First Hawaiian, a Hawaii-focused regional bank with an asset-sensitive balance sheet. The next CPI print will determine whether the rate tailwind persists.
New Fortress Energy’s UK court permission to convert debt to equity signals distress that could ripple through leveraged LNG infrastructure names. Creditor vote next.
Amazon shares slipped 1.02% to $267.38, but the stock is near record highs and a $3 trillion market cap. The next move hinges on AWS cloud revenue and AI demand.
Tower Semiconductor's role in AI photonics supply chain creates a bottleneck risk that could unwind if demand shifts. Next catalyst: Q2 earnings.
Yardeni warns that persistent above-target inflation and energy shocks could force the Fed to reintroduce rate-hike risk, repricing short-term Treasury ETFs.
GAAP EPS of -$0.71 missed consensus by $0.02, while revenue of $1.08B topped estimates by $60M. The divergence points to margin pressure from falling module prices.
The Nifty 50 is holding above 23,500 as put writers defend the strike and FIIs turn buyers. The next move hinges on a close above the 23,550-23,600 band or a break below 23,450.
A falling trendline test at ₹2,532 sets up a potential swing to ₹2,975 by year-end. The trade plan splits entries, defines a hard stop, and scales out with trailing stops.
Lulu’s Fashion Lounge (LVLU) projects positive adjusted EBITDA for 2026 with a lean $2.0M-$2.5M capex plan, shifting the narrative from survival to free cash flow breakeven.
Emrosi growth and PBM/GPO access gains underpin the outlook. The next catalyst is the pace of sales-force expansion and its impact on prescription volumes.
Cytosorbents' Q1 call set operating cash flow breakeven for 2H 2026 and a DrugSorb-ATR de novo submission in late 2026/early 2027. The DOAC removal market offers upside if the FDA clears the device.